Back to news
  • Publications
Sep 30, 2025null min read

EYELIGHT Study Confirms Long-Lasting Efficacy and Safety of Redensity® 2 in Periorbital Rejuvenation

The EYELIGHT study confirms the proven efficacy and trusted safety of Redensity® 2 for periorbital rejuvenation. Results demonstrate natural, long-lasting improvements with high patient satisfaction and excellent tolerability.

At Teoxane, we are proud to share new clinical evidence supporting the performance of TEOSYAL® PureSense Redensity 2 (R2), our hyaluronic acid-based filler specifically developed for the delicate eye contour. Results from the EYELIGHT study, recently published, highlight both the proven efficacy and strong safety profile of Redensity® 2 across multiple periorbital areas.

 

About the EYELIGHT Study

Conducted in the UK and France on over 130 patients, EYELIGHT was a prospective, real-world observational study led by Teoxane’s Clinical Department. In line with everyday practice, physicians applied their own techniques and injection strategies, ensuring that results reflect authentic clinical use.

 

Outstanding Results

  • Over 75% of patients showed visible aesthetic improvement at 3 months, with results maintained up to 12 months post-treatment.
  • More than 80% of participants reported satisfaction with their outcomes, while 99% of practitioners described the product as easy to use.
  • Minimal touch-ups were required, demonstrating the durability and integration of Redensity® 2.

 

A Trusted Safety Profile

Safety was a key focus of the study. Across nearly 1,000 injections, only mild, short-lived side effects were reported. No serious adverse events occurred, confirming once again the excellent tolerability of Redensity® 2 in this sensitive area.

 

Expert Insight
 

“Keeping the eye contour looking youthful is one of the most common requests in aesthetic practice,” explains Dr. Tahera Bhojani-Lynch, study investigator. “These results confirm the long-standing success of Redensity® 2 in tear trough treatment, while demonstrating its effectiveness across the wider periorbital region.”

 

About Redensity® 2 


Teosyal PureSense Redensity® 2 is the first dermal filler specifically designed for periorbital rejuvenation. Combining crosslinked and non-crosslinked hyaluronic acid, it provides natural-looking results with minimized risk of swelling, making it the trusted choice of practitioners worldwide for over a decade.